Search results for " vaccine"

showing 10 items of 680 documents

Safety and efficacy of novel dermal and epidermal microneedle delivery systems for rabies vaccination in healthy adults.

2010

International audience; In the present pilot study, intradermal ID delivery systems with a BD microneedle from 1 to 3mm in length, and epidermal delivery (BD skin abrader) through abraded skin surface relative to standard intramuscular injection were evaluated. Circulating neutralizing antibodies were measured against the rabies virus after the Vero cells rabies vaccine was administered at D0, D7, D21 and D49. This clinical evaluation in 66 healthy volunteers shows that ID delivery using BD microneedle technology of 1/4 the IM antigen dose is safe, efficient and reliable, resulting in a protective seroconversion rate. In contrast, the epidermal delivery route did not produce an immune respo…

Pilot Projectsmedicine.disease_causeAntibodies ViralMESH: Antibodies Neutralizing0302 clinical medicineRabies vaccine030212 general & internal medicineViralMononegaviralesNeutralizingSkin0303 health sciencesIntramuscularbiologyintegumentary systemVaccinationMESH: Rabies VaccinesMESH: Injections Intramuscular3. Good healthVaccinationInfectious DiseasesNeedlesMESH: Young Adult[SDV.MP.VIR]Life Sciences [q-bio]/Microbiology and Parasitology/VirologyMolecular MedicineFemalemedicine.drugAdultInjections IntradermalAdolescentRabiesInjections IntramuscularAntibodiesInjections03 medical and health sciencesYoung AdultMESH: RabiesMESH: SkinIntradermalmedicineHumansSeroconversionLyssavirus030304 developmental biologyMESH: AdolescentMESH: Injections IntradermalMESH: HumansGeneral VeterinaryGeneral Immunology and Microbiologybusiness.industryRabies virusPublic Health Environmental and Occupational HealthMESH: AdultMESH: VaccinationRhabdoviridaebiology.organism_classificationmedicine.diseaseMESH: Pilot ProjectsVirologyAntibodies NeutralizingRabies VaccinesMESH: NeedlesImmunologyRabiesbusinessMESH: FemaleMESH: Antibodies Viral
researchProduct

Clinical recrudescence of chronic untreated P. malariae infection after BNT162b2 CoVID-19 vaccine

2022

We described a case of clinical reactivation of chronic P. malariae infection following CoVID-19 vaccination with BNT162b2 (Pifzer-Biontech CoVID-19 vaccine) in a 48-year old Italian man.The patient came to our attention for fever of unknown origin show a quartan pattern (every third day) associated to splenomegaly, the onset of the fever occurred one month after CoVID-19 vaccination with BNT162b2. P. malariae was diagnosed using CarestartTM malaria rapid test and Polymerase-Chain Reaction. Post-vaccine transient reduction of immune reactivity is described in literature, although the mechanism is unknown.(c) 2022 Published by Elsevier Ltd.CC_BY_NC_ND_4.0

Plasmodium malariaeInfectious DiseasesPlasmodium malariae.BNT162b2Chronic malariaBNT162b2; Chronic malaria; CoVID-19 vaccine; Malaria; Plasmodium malariaeCoVID-19 vaccineMalariaIDCases
researchProduct

Monitoring serologic response to single in ovo vaccination with an immune complex vaccine against infectious bursal disease in broilers

2021

Este artículo se encuentra disponible en la siguiente URL: https://www.sciencedirect.com/science/article/pii/S003257912100033X The infectious bursal disease (IBD) virus is one of the most resistant and prevalent virus worldwide in the poultry industry, being vaccination the main tool to control the disease. For this reason, consistent and uniform immunization of broiler flocks against IBD is necessary to avoid the disease spreading. The aim of this study was to apply and assess an epidemiologic mapping tool focused on the immunization by in ovo single broiler vaccination using an immune complex IBD vaccine. With this regard, 7,576 serum samples were collected from 603 broiler flocks raised …

Pollos - Inmunología.animal diseasesChickens - Vaccination.IBDAntigen-Antibody ComplexChick EmbryoAntibodies ViralIn ovobroilerInfectious bursal disease virusSerologyInfectious bursal diseaseGeoServerIMMUNOLOGY HEALTH AND DISEASEAnimalsMedicineSeroprevalenceAves de corral - Enfermedades.Poultry - Diseases.Pollos - Enfermedades.Poultry DiseasesOvumlcsh:SF1-1100business.industryViral VaccinesGeneral MedicineBirnaviridae Infectionsmedicine.diseasevaccinationVaccinationTiterImmunizationChickens - Diseases.ImmunologyChickens - Immunology.Animal Science and ZoologyELISAFlocklcsh:Animal culturePollos - Vacunación.businessChickens
researchProduct

Breastfeeding and COVID-19 vaccination: position statement of the Italian scientific societies

2021

AbstractThe availability of a COVID-19 vaccine has raised the issue of its compatibility with breastfeeding. Consequently, the Italian Society of Neonatology (SIN), the Italian Society of Pediatrics (SIP), the Italian Society of Perinatal Medicine (SIMP), the Italian Society of Obstetrics and Gynecology (SIGO), the Italian Association of Hospital Obstetricians-Gynecologists (AOGOI) and the Italian Society of Infectious and Tropical Diseases (SIMIT) have made an ad hoc consensus statement. Currently, knowledge regarding the administration of COVID-19 vaccine to the breastfeeding mother is limited. Nevertheless, as health benefits of breastfeeding are well demonstrated and since biological pl…

Position statementmedicine.medical_specialtyCOVID-19 VaccinesConsensusCoronavirus disease 2019 (COVID-19)BreastfeedingBreastfeedingConsensuHealth benefits03 medical and health sciences0302 clinical medicineObstetrics and gynaecology030225 pediatricsMedicalMedicineHumans030212 general & internal medicineVaccination.Societies Medicalbusiness.industryVaccinationlcsh:RJ1-570COVID-19lcsh:PediatricsBreastfeeding; COVID-19; Vaccination; COVID-19; Consensus; Female; Humans; Italy; Societies Medical; Breast Feeding; COVID-19 VaccinesSettore MED/38VaccinationBreast FeedingItalyFamily medicineCommentaryFemaleBiological plausibilitybusinessSocietiesBreast feedingHuman
researchProduct

Pneumococcal conjugate vaccines: proceedings from an Interactive Symposium at the 41st Interscience Conference on Antimicrobial Agents and Chemothera…

2003

Globally, Streptococcus pneumoniae is a leading cause of invasive and noninvasive disease in infants and young children. The emergence of antibiotic-resistant strains has increased interest in prevention through immunization. Currently, the only available conjugate pneumococcal vaccine is a seven-valent formulation, PNCRM7. This paper presents excerpts from a symposium that provided an update of ongoing surveillance data and clinical trials evaluating pneumococcal conjugate vaccines. The topics addressed included: (1) PNCRM7 postmarketing safety data; (2) the impact of PNCRM7 in premature infants; (3) the direct and indirect effect of pneumococcal conjugate vaccines on colonization; (4) the…

Potential impactChemotherapymedicine.medical_specialtyGeneral VeterinaryGeneral Immunology and Microbiologybusiness.industrymedicine.medical_treatmentPublic Health Environmental and Occupational HealthAntimicrobialmedicine.disease_causeClinical trialInfectious DiseasesPneumococcal vaccineImmunizationStreptococcus pneumoniaeImmunologyMolecular MedicineMedicinebusinessIntensive care medicineConjugateVaccine
researchProduct

Immunological analyses of human papillomavirus capsids

2001

Recombinant human papillomavirus (HPV) virus-like particles (VLPs) are promising vaccine candidates for controlling anogenital HPV disease. Questions remain, however, concerning the extent of capsid antigenic similarity between closely related virus genotypes. To investigate this issue, we produced VLPs and corresponding polyclonal immune sera from several anogenital HPV types, and examined these reagents in enzyme-linked immunosorbent assays (ELISAs) and in cross-neutralization studies. Despite varying degrees of L1 genetic sequence relatedness, VLPs of each type examined induced high-titer serum polyclonal antibody responses that were entirely genotype-specific. In an in vitro infectivity…

Protein DenaturationGenotypeProtein ConformationvirusesEnzyme-Linked Immunosorbent AssayVaccinia virusCross ReactionsBiologyAntibodies ViralRecombinant virusEpitopeVirusAbsorptionEpitopesCapsidVirus-like particleAntibody SpecificityNeutralization TestsAntigenic variationHumansSerotypingAntigens ViralPapillomaviridaeAntiserumVaccines SyntheticGeneral VeterinaryGeneral Immunology and MicrobiologyImmune SeraViral VaccinePublic Health Environmental and Occupational HealthAntibodies Monoclonalvirus diseasesViral VaccinesVirologyInfectious DiseasesCapsidMolecular MedicineVaccine
researchProduct

A proteomic-based approach for the identification ofCandida albicans protein components present in a subunit vaccine that protects against disseminat…

2006

Candidiasis has become a prevalent infection in different types of immunocompromised patients. The cell wall of Candida albicans plays important functions during the host-fungus interactions. Cell wall (surface) proteins of C. albicans are major elicitors of host immune responses during candidiasis, and represent candidates for vaccine development. Groups of mice were vaccinated subcutaneously with a beta-mercaptoethanol (beta-ME) extract from C. albicans containing cell wall proteins. Vaccinated mice were then infected with a lethal dose of C. albicans. Increased survival and decreased fungal burden were observed in vaccinated mice as compared to a control group, and 75% of vaccinated mice…

ProteomicsAntigens FungalBiochemistryImmunoproteomicsMicrobiologyMiceImmune systemAntigenCandida albicansAnimalsElectrophoresis Gel Two-DimensionalCandida albicansMolecular BiologyMercaptoethanolMice Inbred BALB CbiologyVaccinationCandidiasisbiology.organism_classificationDisseminated CandidiasisVirologyCorpus albicansVaccinationSpectrometry Mass Matrix-Assisted Laser Desorption-Ionizationbiology.proteinFemaleFungal VaccinesAntibodyPROTEOMICS
researchProduct

Vaccination with TAT-Antigen Fusion Protein Induces Protective, CD8+ T Cell-Mediated Immunity Against Leishmania Major

2010

In murine leishmaniasis, healing is mediated by IFN-γ-producing CD4 + and CD8 + T cells. Thus, an efficacious vaccine should induce Th1 and Tc1 cells. Dendritic cells (DCs) pulsed with exogenous proteins primarily induce strong CD4-dependent immunity; induction of CD8 responses has proven to be difficult. We evaluated the immunogenicity of fusion proteins comprising the protein transduction domain of HIV-1 TAT and the Leishmania antigen LACK ( Leishmania homolog of receptors for activated C kinase), as TAT-fusion proteins facilitate major histocompatibility complex class I-dependent antigen presentation. In vitro , TAT–LACK-pulsed DCs induced stronger proliferation of Leishmania -specific C…

Protozoan VaccinesAntigen presentationProtozoan ProteinsLeishmaniasis CutaneousAntigens ProtozoanDermatologyCD8-Positive T-LymphocytesBiologyMajor histocompatibility complexBiochemistryArticleMiceAntigenAnimalsCytotoxic T cellLeishmania majorMolecular BiologyLeishmania majorImmunogenicityDendritic CellsCell BiologyTh1 Cellsbiology.organism_classificationInterleukin-12Fusion proteinMice Mutant StrainsCell biologyMice Inbred C57BLImmunologybiology.proteintat Gene Products Human Immunodeficiency VirusViral Fusion ProteinsCD8Journal of Investigative Dermatology
researchProduct

Speculation on whether a vaccine against cryptosporidiosis is a reality or fantasy

1999

In this paper the authors question whether the development of a vaccine against cryptosporidiosis could be taken into consideration. The necessity and feasibility of such a vaccine for human and veterinary application is discussed. Developmental stages within the life cycle of the parasite that might act as possible targets for vaccine development are summarised, as well as the target antigens offered by molecular biology and immunology studies. Vaccination trials against cryptosporidiosis carried out so far, including the active and passive immunisation approach, are also overviewed. It seems that with respect to a Cryptosporidium vaccine two target groups can be considered: children of th…

Protozoan VaccinesRuminantCloneProtozoan ProteinsTarget groupsCryptosporidiosisRuminant animalArticleImmunityAnimalsHumansImmune responseSpeculationCryptosporidium parvumbiologyCryptosporidiumbiology.organism_classificationVaccinationInfectious DiseasesCryptosporidium parvumAntigenApical organellesPassive immunisationImmunologyParasitologyVaccineHumanInternational Journal for Parasitology
researchProduct

Expression of B-Cell Activating Factor Enhances Protective Immunity of a Vaccine against Pseudomonas aeruginosa

2009

ABSTRACT B-cell activating factor (BAFF), a member of the TNF family, is a potent cytokine with stimulatory effects on B and T cells. To evaluate the potential of transient overexpression of BAFF to enhance vaccine immunogenicity, a replication-deficient adenovirus expressing full-length murine BAFF (AdBAFF) was tested in a mouse vaccine model against Pseudomonas aeruginosa . When coadministered with heat-killed P. aeruginosa , AdBAFF mediated a significant increase in anti- P. aeruginosa- specific serum and lung mucosal antibodies and resulted in improved protection against a lethal respiratory challenge with P. aeruginosa . This effect was independent of the site of administration of AdBA…

Pseudomonas Vaccinesmedicine.medical_treatmentGenetic VectorsImmunologyBiologymedicine.disease_causeMicrobiologyAdenoviridaeMicrobiologyMiceImmune systemAdjuvants ImmunologicImmunityB-Cell Activating FactorPneumonia BacterialmedicineAnimalsB-cell activating factorImmunity MucosalPseudomonas aeruginosaAntibodies BacterialSurvival AnalysisMice Inbred C57BLInfectious DiseasesCytokineVaccines InactivatedImmunizationMicrobial Immunity and VaccinesPseudomonas aeruginosaImmunologybiology.proteinFemaleParasitologyAntibodyAdjuvantInfection and Immunity
researchProduct